• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TYP

TRYPTAMINE THERAPEUTICS LIMITED

3.13% ! 3.3¢
Market Cap $45.83M  !

Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology... Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on the development of an advanced and scalable intravenous-infused psilocin formulation, which can be used in conjunction with psychotherapy to address significant unmet medical needs. It is focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. It intends to accomplish this through the development of an IV infusion of psilocin (the active metabolite of psilocybin). Its lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. The Company is engaged in pursuing Phase II clinical trials using its psilocybin and psilocin-based drug products for chronic pain and eating disorders. The Company's pipeline products include TRP-8803 and TRP-8802.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
TYP 22/07/25 3 894
22/07/25 Last post  easysell Comments Created with Sketch.  3  Views Created with Sketch.  894 
TYP
Tryptamine enrolling binge eaters for magic mushrooms study
21/07/25 0 273
21/07/25 Last post  ASX Insights Comments Created with Sketch.  0  Views Created with Sketch.  273 
TYP 16/07/25 3 1.0K
TRENDING NEWS

The DealRoom: New Investment Opportutnity Now Live

NEWS
23 Jul 2025
16/07/25 Last post  IndexInvestor Comments Created with Sketch.  3  Views Created with Sketch.  1.0K 
TYP
TYP - Media & News
11/07/25 31 22K
11/07/25 Last post  craggles66 Comments Created with Sketch.  31  Views Created with Sketch.  22K 
TYP
JC appointed non-exec Chair of ILA
02/07/25 2 817
02/07/25 Last post  Mooncat Comments Created with Sketch.  2  Views Created with Sketch.  817 
TYP 27/06/25 11 3.8K
27/06/25 Last post  easysell Comments Created with Sketch.  11  Views Created with Sketch.  3.8K 
TYP 26/06/25 1 768
26/06/25 Last post  NZ Trader Comments Created with Sketch.  1  Views Created with Sketch.  768 
TYP 19/05/25 0 474
19/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  474 

See All Discussions arrow Created with Sketch.

Timeline

Patient recruitment for world first TRP-8803 trial underway
21 Jul 08:26
 
Key appointments strengthen TRP-8803 clinical development
16 Jul 08:53
 
Investor Presentation
26 Jun 09:09
 
Binge Eating Disorder Trial receives Human Ethics approval
23 Jun 09:33
 
Notification of cessation of securities - TYP
19 May 15:06
 
Release from Escrow
16 May 11:32
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
3.3¢
Change
0.001(3.13%)
Mkt cap ! $45.83M
Open High Low Value Volume
3.3¢ 3.3¢ 3.1¢ $64.97K 2.060M

Buyers (Bids)

No. Vol. Price($)
4 246160 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 538789 3
View Market Depth
Last trade - 15.56pm 23/07/2025 (20 minute delay) ?
Last
3.3¢
  Change
0.001 ( 6.45 %)
Open High Low Volume
3.2¢ 3.3¢ 3.1¢ 232192
Last updated 14.41pm 23/07/2025 ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.